GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (LTS:0A9W) » Definitions » Price-to-Funds-From-Operations

Organon (LTS:0A9W) Price-to-Funds-From-Operations : (As of Jun. 07, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Organon Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Organon (LTS:0A9W) Business Description

Industry
Traded in Other Exchanges
Address
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.